Get the Stockscreener App
2.44
4.69%
-0.12
After Hours:
2.44
Fortress Biotech Inc stock is traded at $2.44, with a volume of 530.54K.
It is down -4.69% in the last 24 hours and down -11.27% over the past month.
Fortress Biotech Inc is a biopharmaceutical company. The firm is involved in the business of acquiring, developing, and commercializing pharmaceutical and biotechnology products. Its product portfolio encompasses Qbrexza, Accutane, Amzeeq, Zilxi, Targadox, Ximino, and Exelderm. The business activities of the group are functioned through Dermatology Product Sales, and Pharmaceutical and Biotechnology Product Development. It derives the majority of its revenues from Dermatology segment. Its subsidiaries also operate in biotechnology, pharmaceutical, oncology and therapeutics sectors.
See More
Previous Close:
$2.56
Open:
$2.57
24h Volume:
530.54K
Relative Volume:
0.55
Market Cap:
$72.60M
Revenue:
$80.97M
Net Income/Loss:
$-78.31M
P/E Ratio:
-0.2201
EPS:
-11.0849
Net Cash Flow:
$-129.56M
1W Performance:
-5.06%
1M Performance:
-11.27%
6M Performance:
+33.33%
1Y Performance:
+28.42%
1-Day Range:
$2.39
$2.57
1-Week Range:
$2.39
$2.65
52-Week Range:
$1.325
$4.20
Fortress Biotech Inc Stock (FBIO) Company Profile
Name
Fortress Biotech Inc
Sector
Industry
Phone
781-652-4500
Address
1111 KANE CONCOURSE, BAY HARBOR ISLANDS, NY
Compare FBIO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
FBIO
Fortress Biotech Inc
|
2.44 | 76.17M | 80.97M | -78.31M | -129.56M | -11.08 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.11B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
642.25 | 68.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
434.07 | 60.25B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
826.28 | 50.39B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
186.23 | 40.44B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fortress Biotech Inc Stock (FBIO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-15-24 | Resumed | ROTH MKM | Buy |
| Aug-04-22 | Initiated | Ladenburg Thalmann | Buy |
| Oct-02-20 | Initiated | The Benchmark Company | Buy |
| Dec-18-19 | Initiated | B. Riley FBR | Buy |
| Feb-28-18 | Initiated | B. Riley FBR, Inc. | Buy |
| Jul-11-17 | Initiated | Rodman & Renshaw | Buy |
| Mar-22-17 | Initiated | JMP Securities | Mkt Outperform |
| Oct-03-16 | Initiated | ROTH Capital | Buy |
View All
Fortress Biotech Inc Stock (FBIO) Latest News
Can a trend reversal in Fortress Biotech Inc. lead to recovery2025 Retail Activity & Target Return Focused Stock Picks - newser.com
Will Fortress Biotech Inc. stock outperform Nasdaq indexWeekly Investment Summary & Technical Pattern Based Signals - newser.com
What earnings revisions data tells us about Fortress Biotech Inc.Volume Spike & Weekly Watchlist for Hot Stocks - newser.com
Developing predictive dashboards with Fortress Biotech Inc. dataJuly 2025 Levels & Verified Swing Trading Watchlist - newser.com
How Fortress Biotech Inc. stock benefits from tech adoptionJuly 2025 Price Swings & Expert Curated Trade Setup Alerts - newser.com
Can Fortress Biotech Inc. stock attract ESG capital inflowsEarnings Trend Report & Reliable Entry Point Trade Alerts - newser.com
Can Fortress Biotech Inc. stock double in next 5 years2025 Technical Overview & High Accuracy Swing Entry Alerts - newser.com
Why Fortress Biotech Inc. stock could be next big winnerVolume Spike & Real-Time Price Movement Reports - newser.com
Is Fortress Biotech Inc. stock reversal real or fakeJuly 2025 PostEarnings & Advanced Swing Trade Entry Plans - newser.com
Should I hold or sell Fortress Biotech Inc. stock in 2025Earnings Growth Report & Long-Term Growth Portfolio Plans - newser.com
Exit strategy if you’re trapped in Fortress Biotech Inc. - newser.com
Will Fortress Biotech Inc. stock maintain momentum in 2025July 2025 Snapshot & AI Powered Market Entry Ideas - fcp.pa.gov.br
Is Fortress Biotech Inc. stock positioned well for digital economyOptions Play & Community Verified Trade Signals - fcp.pa.gov.br
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Fortress Biotech Inc.FBIO - WV News
Little Excitement Around Fortress Biotech, Inc.'s (NASDAQ:FBIO) Revenues As Shares Take 34% Pounding - 富途牛牛
What high frequency data says about Fortress Biotech Inc.July 2025 Pullbacks & Expert Verified Movement Alerts - newser.com
Big Announcements Hammer Biotech And AI Shares - Finimize
Buyback Watch: Can Fortress Biotech Inc. stock outperform in 2025 bull marketTreasury Yields & Community Consensus Picks - Fundação Cultural do Pará
Weiss Ratings Reiterates Sell (D-) Rating for Fortress Biotech (NASDAQ:FBIO) - MarketBeat
Fortress Biotech Inc Stock (FBIO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.64%
0.35%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):